REVIEW article

Front. Oncol.

Sec. Head and Neck Cancer

Volume 15 - 2025 | doi: 10.3389/fonc.2025.1597086

This article is part of the Research TopicMultidisciplinary Management of Oral Cancer: Diagnosis, Treatment, and RehabilitationView all 10 articles

Recent advances in biomarker detection of oral squamous cell carcinoma

Provisionally accepted
Lan  LiuLan LiuXiaowu  ZhongXiaowu ZhongYue  ZhongYue ZhongLihua  LiLihua Li*
  • Affiliated Hospital of North Sichuan Medical College, Nanchong, China

The final, formatted version of the article will be published soon.

Oral squamous cell carcinoma is among the most prevalent tumours of the oral and maxillofacial region.The initial symptoms are typically minor and may remain misdiagnosed until the disease advances, resulting in a significantly reduced five-year survival rate for patients. Early detection is critical, as it can improve five-year survival rates from below 50% to 70-90%. Due to their reduced sensitivity and intrusive nature, conventional screening methods such as serological testing and histopathological biopsies have limitations in their application. In contrast, emerging technologies including single-cell sequencing, spatial transcriptomics, nanopore sequencing, biosensor technology, and artificial intelligence, among other advanced detection methods, are redefining biomarker discovery. Scalability obstacles still exist, including clinical validation gaps, high implementation costs, and analytical complexity. In order to close the gap between invention and equitable implementation, future efforts should focus on multicenter validation of potential biomarkers and cost-effective integration of these technologies. This will ultimately improve patient prognosis and quality of life. This work aims to comprehensively investigate and evaluate the prospective applications and future developmental potential of these technologies while offering an extensive examination of oral squamous cell cancer biomarker research.

Keywords: oral squamous cell carcinoma, Single-cell sequencing technology, Spatial transcriptomics, nanopore sequencing, Artificial intelligence technology, Biosensor technology

Received: 20 Mar 2025; Accepted: 26 May 2025.

Copyright: © 2025 Liu, Zhong, Zhong and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Lihua Li, Affiliated Hospital of North Sichuan Medical College, Nanchong, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.